Literature DB >> 4926872

An experimental model of active immunotherapy preceded by cytoreductive chemotherapy.

J L Amiel, M Berardet.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 4926872     DOI： 10.1016/0014-2964(70)90078-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  New experimental and clinical data on leukaemia immunotherapy.

Authors:  G Mathé; L Schwarzenberg; J L Amiel; P Pouillart; M Hayat; F de Vassal; C Rosenfeld; C Jasmin
Journal:  Proc R Soc Med       Date:  1975-04

2.  A patient with gastric carcinoma improved remarkably on intraperitoneal OK-432 therapy.

Authors:  H Yamagishi; H Ishibashi; M Kodama; T Tanaka; Y Harada; I Hashimoto
Journal:  Jpn J Surg       Date:  1982

3.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

4.  Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.

Authors:  G M Taylor; R Harris; C B Freeman
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.